Grant: Collaborative Health Research Projects
University of Toronto
$114,710.00
Bioengineered cell delivery system
EF 2013-14
Résumé
Traumatic spinal cord injury is often described in terms of the primary injury, which results from a mechanicalinsult such as a motor vehicle or sports-related accident, and the secondary injury, which results in a cascade ofevents, resulting in an inhibitory environment. The latter limits regeneration by forming a scar-like tissuewhich can be degraded. The environment in the injured spinal cord is not conducive to cell growth; however,cell transplantation holds promise for regeneration.Here we propose to both degrade the scar-like tissue that forms after injury and deliver stem cells that willpromote regeneration. Critical challenges in the development of stem cell based therapies, are the survival oftransplanted cells and tissue integration within the host. By addressing both with novel bioengineeringstrategies in combination with advanced stem cell biology and animal models, we anticipate developingplatform strategies that will impact spinal cord injury repair strategies and be broadly applicable to othertraumatic or neurodegenerative diseases of the central nervous system, such as stroke and retinal degeneration.Our team has the collective expertise required for success. By bringing together world-leading experts inbioengineering, stem cell biology, cellular microenvironment and spinal cord injury models, we aim toovercome injury in one of the most challenging frontiers in medicine - the central nervous system. We willprovide a superb training environment for our researchers, taking advantage of the multidisciplinary approachto overcome spinal cord injury. Our team is strengthened by our three industrial collaborators with expertise incommercialization of research, scar tissue degradation, and stem cell delivery. Together, we aim to advanceknowledge towards commercial products in the fields of regenerative medicine and neuroscience - two focusareas identified by the Federal government for funding.
Programme
Collaborative Health Research Projects
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
398138-2011
Name nom
Shoichet, Molly
Department département
Chemical Engineering and Applied Chemistry
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2011
Award amount
114710
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1902
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical materials
Research subject fr
Matériaux biomédicaux
Partie
3
Nb partie
3
Application title
Bioengineered cell delivery system
Keyword
NSERC
Application summary
Traumatic spinal cord injury is often described in terms of the primary injury, which results from a mechanicalinsult such as a motor vehicle or sports-related accident, and the secondary injury, which results in a cascade ofevents, resulting in an inhibitory environment. The latter limits regeneration by forming a scar-like tissuewhich can be degraded. The environment in the injured spinal cord is not conducive to cell growth; however,cell transplantation holds promise for regeneration.Here we propose to both degrade the scar-like tissue that forms after injury and deliver stem cells that willpromote regeneration. Critical challenges in the development of stem cell based therapies, are the survival oftransplanted cells and tissue integration within the host. By addressing both with novel bioengineeringstrategies in combination with advanced stem cell biology and animal models, we anticipate developingplatform strategies that will impact spinal cord injury repair strategies and be broadly applicable to othertraumatic or neurodegenerative diseases of the central nervous system, such as stroke and retinal degeneration.Our team has the collective expertise required for success. By bringing together world-leading experts inbioengineering, stem cell biology, cellular microenvironment and spinal cord injury models, we aim toovercome injury in one of the most challenging frontiers in medicine - the central nervous system. We willprovide a superb training environment for our researchers, taking advantage of the multidisciplinary approachto overcome spinal cord injury. Our team is strengthened by our three industrial collaborators with expertise incommercialization of research, scar tissue degradation, and stem cell delivery. Together, we aim to advanceknowledge towards commercial products in the fields of regenerative medicine and neuroscience - two focusareas identified by the Federal government for funding.